GlobalDeal

Agomab

Biotechnology · Antwerp, Belgium

agomab.com

About Agomab

Agomab is a biotechnology company focused on developing innovative therapies for patients with serious diseases. The company specializes in the discovery and development of monoclonal antibodies and other biologics that target specific pathways involved in disease processes. Agomab aims to address unmet medical needs through its proprietary technology platforms and a robust pipeline of drug candidates. The company collaborates with various research institutions and industry partners to advance its therapeutic candidates from preclinical stages to clinical trials, ensuring a strong commitment to scientific excellence and patient care.

Company facts

Industry
Biotechnology
Sub-industries
Monoclonal Antibodies, Biologics, Pharmaceuticals, Drug Development, Clinical Research
Location
Antwerp, Belgium
Employees
11–50
Revenue (USD)
1–5M
Founded
2018

Products and services

Open Agomab in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in Belgium

All 375 Biotechnology companies in Belgium →